Lv2
116 积分 2025-06-23 加入
EMERGING MEDICINAL CHEMISTRY APPROACHES TO MODULATE TRANSCRIPTIONAL ACTIVITY BY ACETYLATION
2天前
已完结
Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK
12天前
已完结
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies
24天前
已完结
DeepDegradome: A structure-aware deep learning framework for PROTAC and ligand generation against protein targets
1个月前
已完结
Nickel-Catalyzed Cross-Electrophile Reductive Couplings of Neopentyl Bromides with Aryl Bromides
2个月前
已完结
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
2个月前
已完结
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
2个月前
已关闭
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
2个月前
已关闭
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
2个月前
已关闭
A Phase 1, Open-Label, Single Ascending Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ES-481 After Oral Administration in Healthy Volunteers
2个月前
已关闭
皖公网安备34019202002308
